CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Final results of the first phase I study of intraperitoneal administration of GL-ONC1, a marker gene modified vaccinia virus, in patients with peritoneal carcinomatosis
DOI 10.1055/s-0035-1559230
Bibliografische Angaben
Nachweis in CareLit
Autor:innenU Lauer, M Zimmermann, J Beil, S Berchtold, U Koppenhöfer, J Glatzle, A Königsrainer, R Möhle, D Nann, F Fend, C Pfannenberg, M Bitzer, N Malek
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe08/2015
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Introduction: We here report on our final results of a phase I study of intraperitoneal (i.p.) administration of the virotherapeutic drug GL-ONC1 in patients exhibiting advanced stage peritoneal carcinomatosis (PC). GL-ONC1 is a recombinant Vaccinia virus genetically engineered to selectively replicate in and destroy cancer cells. Methods: GL-ONC1 was administered i.p. every 4 weeks for up to 4 cycles at 3 different…
Zitieren
Zitierempfehlung
U Lauer, M Zimmermann, J Beil, S Berchtold, U Koppenhöfer, J Glatzle, A Königsrainer, R Möhle, D Nann, F Fend, C Pfannenberg, M Bitzer, N Malek (2015) Final results of the first phase I study of intraperitoneal administration of GL-ONC1, a marker gene modified vaccinia virus, in patients with peritoneal carcinomatosis. Zeitschrift für Gastroenterologie (08). https://doi.org/10.1055/s-0035-1559230
Mit CareLit weiterarbeiten